Oxford, UK, May 30, 2024: Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has launched its multimodal therapy...

UConn Health has integrated Optellum's Virtual Nodule Clinic (VNC) in their workflow to aid in the detection and management of lung cancer. Lung cancer is...

Dr. K. Adam Lee is on the frontlines of helping patients fight the deadliest form of cancer: lung cancer. The board-certified thoracic surgeon has...

Researchers believe new AI software could help doctors detect lung cancer at an earlier stage and deliver more effective treatments for patients. Lung cancer...

By Carrie Hart, Director of Market Access at Optellum Summary In an effort to improve patient outcomes, hospitals innovate and invest in new technologies...

Lung Cancer Awareness Month is a poignant reminder of the urgent need to spotlight one of the most prevalent and deadliest forms of cancer...

CAMBRIDGE, Mass., Oct. 17, 2023: ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today its strategic collaboration with Optellum Ltd (Oxford, UK), a...

By Rhiannon Lassiter, Head of Communications and Marketing at Optellum This piece was first published in AIthority 2023 has seen a leap forward in...

Optellum partners, GE Healthcare, have published an insights article about Optellum's Virtual Nodule Clinic and the advantages clinicians have seen from using the system....

By Ryan Hennen, VP of US sales, Optellum Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying...

Clinicians from top US healthcare centers demonstrate the benefits of AI-assisted early lung cancer diagnosis at this year’s American Thoracic Society (ATS) International Conference....

A paper published in JAMA Network Open shows the potential for deep learning algorithms to assign individuals to two-year screening intervals, reducing the harm...

Vaclav joined TechRound editor to talk about how Optellum has evolved since being founded to becoming the leader in AI diagnosis. My aunt was...

AtlantiCare joined leading healthcare systems worldwide by becoming the first system in the northeastern U.S. to use the Optellum Virtual Nodule Clinic. EGG HARBOR...

By Ryan Hennen, VP of US sales, Optellum Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying...

Jason joined Natalie Harms, the editor of Innovation Map, to talk about Optellum's journey and his career as a serial innovator with roles at...

CB Insights, a market research and business analytics firm, has released its annual ranking of the 150 most promising digital health startups, including Optellum. The...

Lung cancer is the leading cause of cancer deaths worldwide, with approximately 1.8 million people dying from lung cancer each year. The majority of...

In October 2022, the American College of Chest Physicians (CHEST) held its Annual Meeting in Nashville, Tennessee, and the Optellum team was there to...

Members of the Optellum team gathered in Marseille, alongside clinicians and innovators specialising in lung health, to attend the 22nd WCBIP/WCBE World Congress organised...

Lead investor Mercia, alongside Intuitive Ventures and Black Opal, invests inOptellum’s pioneering AI-powered lung-health technology Oxford, 27 September 2022, 8am: Optellum, an Oxford-based medtech...

Once a year, the American Association for Bronchology and Interventional Pulmonology gather the bright minds of innovators and industry experts working in pulmonology and...

The International Association for the Study of Lung Cancer (IASLC) hosted its annual conference in Vienna, Austria and the Optellum team were glad to...

At the recent American Thoracic Society (ATS) annual meeting, Dr Michael Gregory Lester MD and Dr Fabien Maldonado MD, of Vanderbilt University Medical Centre,...